According to Fact.MR, Revenue Share of Peptide based cancer therapeutics market will surpass a valuation of US$ 11,160 Million by 2022-end, expanding at an impressive CAGR of 9.2% during 2017-2022 Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the […]

Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn. Incessant […]